Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Efavirenz to Atazanavir/Ritonavir for Lipoatrophy in HIV
NCT01194856Phase 4Terminated
- Sponsor
- Cleveland Clinic
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Cleveland Clinic. Started Oct 2010; status: terminated.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01194856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194856.